JP Morgan Chase’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-20,000
| Closed | -$9.34M | – | 7686 |
|
|
2025
Q4 | $9.34M | Hold |
20,000
| – | – | ﹤0.01% | 2749 |
|
|
2025
Q3 | $8.52M | Buy |
+20,000
| New | +$7.75M | ﹤0.01% | 2871 |
|
|
2025
Q2 | – | Sell |
-3,200
| Closed | -$1.11M | – | 7318 |
|
|
2025
Q1 | $1.11M | Sell |
3,200
-56,200
| -95% | -$18.1M | ﹤0.01% | 4269 |
|
|
2024
Q4 | $17.8M | Sell |
59,400
-5,300
| -8% | -$1.85M | ﹤0.01% | 2149 |
|
|
2024
Q3 | $26.3M | Buy |
64,700
+5,300
| +9% | +$1.94M | ﹤0.01% | 1766 |
|
|
2024
Q2 | $19.1M | Buy |
59,400
+13,600
| +30% | +$4.42M | ﹤0.01% | 1904 |
|
|
2024
Q1 | $15.3M | Sell |
45,800
-3,100
| -6% | -$947K | ﹤0.01% | 2116 |
|
|
2023
Q4 | $13.2M | Buy |
48,900
+13,200
| +37% | +$3.26M | ﹤0.01% | 2195 |
|
|
2023
Q3 | $8.78M | Buy |
35,700
+24,300
| +213% | +$6.65M | ﹤0.01% | 2365 |
|
|
2023
Q2 | $3.46M | Buy |
+11,400
| New | +$3.17M | ﹤0.01% | 3141 |
|
|
2023
Q1 | – | Sell |
-25,900
| Closed | -$6.21M | – | 6929 |
|
|
2022
Q4 | $6.21M | Buy |
25,900
+20,800
| +408% | +$4.66M | ﹤0.01% | 2650 |
|
|
2022
Q3 | $937K | Buy |
5,100
+600
| +13% | +$120K | ﹤0.01% | 4053 |
|
|
2022
Q2 | $756K | Hold |
4,500
| – | – | ﹤0.01% | 4285 |
|
|
2022
Q1 | $1.13M | Sell |
4,500
-8,700
| -66% | -$2.18M | ﹤0.01% | 4176 |
|
|
2021
Q4 | $3.39M | Hold |
13,200
| – | – | ﹤0.01% | 3380 |
|
|
2021
Q3 | $3.2M | Buy |
+13,200
| New | +$3.23M | ﹤0.01% | 3404 |
|
|
2021
Q1 | – | Sell |
-85,700
| Closed | -$14.1M | – | 6178 |
|
|
2020
Q4 | $14.1M | Sell |
85,700
-52,700
| -38% | -$7.71M | ﹤0.01% | 1916 |
|
|
2020
Q3 | $16.6M | Buy |
138,400
+78,400
| +131% | +$9.7M | ﹤0.01% | 1619 |
|
|
2020
Q2 | $5.82M | Sell |
60,000
-74,600
| -55% | -$7.76M | ﹤0.01% | 2343 |
|
|
2020
Q1 | $12.1M | Sell |
134,600
-75,100
| -36% | -$9.72M | ﹤0.01% | 1601 |
|
|
2019
Q4 | $31M | Buy |
209,700
+184,700
| +739% | +$24.8M | 0.01% | 1257 |
|
|
2019
Q3 | $3.01M | Sell |
25,000
-132,400
| -84% | -$17.1M | ﹤0.01% | 3125 |
|
|
2019
Q2 | $21.1M | Buy |
157,400
+118,300
| +303% | +$15M | ﹤0.01% | 1535 |
|
|
2019
Q1 | $5.1M | Sell |
39,100
-65,900
| -63% | -$8.85M | ﹤0.01% | 2568 |
|
|
2018
Q4 | $13.1M | Buy |
105,000
+55,000
| +110% | +$7.38M | ﹤0.01% | 1800 |
|
|
2018
Q3 | $6.96M | Hold |
50,000
| – | – | ﹤0.01% | 2490 |
|
|
2018
Q2 | $5.13M | Hold |
50,000
| – | – | ﹤0.01% | 2664 |
|
|
2018
Q1 | $4.85M | Sell |
50,000
-133,900
| -73% | -$13M | ﹤0.01% | 2604 |
|
|
2017
Q4 | $16.2M | Hold |
183,900
| – | – | ﹤0.01% | 1743 |
|
|
2017
Q3 | $14.5M | Buy |
183,900
+34,300
| +23% | +$2.76M | ﹤0.01% | 1718 |
|
|
2017
Q2 | $13M | Buy |
+149,600
| New | +$12.7M | ﹤0.01% | 1765 |
|
|
2017
Q1 | – | Sell |
-130,000
| Closed | -$9.62M | – | 5123 |
|
|
2016
Q4 | $9.62M | Buy |
+130,000
| New | +$9.74M | ﹤0.01% | 1938 |
|
|
2016
Q1 | – | Sell |
-383,000
| Closed | -$25.9M | – | 4784 |
|
|
2015
Q4 | $25.9M | Buy |
383,000
+350,400
| +1,075% | +$24.4M | 0.01% | 1161 |
|
|
2015
Q3 | $2.52M | Sell |
32,600
-25,900
| -44% | -$2.29M | ﹤0.01% | 2629 |
|
|
2015
Q2 | $5.31M | Buy |
58,500
+26,000
| +80% | +$2.08M | ﹤0.01% | 2355 |
|
|
2015
Q1 | $2.44M | Sell |
32,500
-500,000
| -94% | -$35.9M | ﹤0.01% | 2783 |
|
|
2014
Q4 | $39.1M | Buy |
532,500
+212,500
| +66% | +$14.9M | 0.01% | 1062 |
|
|
2014
Q3 | $22.6M | Buy |
+320,000
| New | +$21.1M | 0.01% | 1374 |
|
Other funds holding HCA
VCM
VPM
JP Morgan Chase's HCA Position: Q1 2026 in Review
JP Morgan Chase increased its HCA Healthcare (HCA) stake by 4.4% in Q1 2026, buying an estimated $51.7M and bringing the position to 2,461,975 shares worth $1.15B. The position accounts for 0.07% of the portfolio, ranked #240.
JP Morgan Chase first reported a position in HCA in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.35B in Q2 2023. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- JP Morgan Chase held 2,461,975 shares of HCA Healthcare worth $1.15B as of Q1 2026.
- JP Morgan Chase bought 102,755 HCA Healthcare shares in Q1 2026, an estimated $51.7M.
- HCA Healthcare made up 0.07% of JP Morgan Chase's portfolio in Q1 2026, its #240 holding.
- JP Morgan Chase first reported a position in HCA Healthcare in Q2 2013 and has held it in 52 quarters since.
- JP Morgan Chase's HCA Healthcare position peaked at $1.35B in Q2 2023.
- 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.